the in vitro activity of vancomycin and teicoplanin , a new glycopeptide antimicrobial , was determined against a total of 286 anaerobic bacteria including bacteroides fragilis group ( 100 ) , b. melaninogenicus ( 21 ) , b. bivius ( 16 ) , fusobacterium spp .
C0042313
vancomycin
C0017953
glycopeptide